Skip to content
Crop Life Science logo

Crop Life Science

CLSL NSE
₹82.00 up 2.90 (3.67%)
Market Cap
₹141 Cr

Crop Life Science (CLSL) share price was ₹82.00 at the 28 Oct 2026 close; market capitalisation ₹141 Cr; sector Chemicals. The share price rose 49.1% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue was ₹87 Cr, against ₹94 Cr a year earlier and net profit was ₹4 Cr, against ₹3 Cr a year earlier (compared with Mar 2025). Promoters held 67.21% of Crop Life Science in Sep 2026, down 2.80 percentage points from Mar 2026. Its Tapetide Score is 46/100 (Average) as of 28 Oct 2026.

Close 28 Oct 2026 ₹82.00 +28.00 +51.85% 1Y

Key Fundamentals

SMEFertilizers & AgrochemicalsChemicals
Market Cap
₹141 Cr
EBITDA
₹19.50 Cr
Return on Equity
7.38%
Return on Capital Employed
15.58%
Debt to Equity
0.67
Book Value
₹49.15
EPS (TTM)
—
52W High
₹92.25
52W Low
₹39.05

Price-based figures as of 28 Oct 2026, 12:08 IST · TTM

Peer Comparison

Commodities › Chemicals › Pesticides & Agrochemicals

₹544.2022.7245,940 Cr1.321.16%5.38%10.85%53,683 Cr2,323 Cr
₹2,107.0027.4331,967 Cr2.850.72%11.76%14.68%6,914 Cr1,164 Cr
₹335.0528.8316,724 Cr4.520.38%16.00%20.98%3,409 Cr581 Cr
₹3,294.1020.2214,804 Cr4.994.59%23.24%27.93%5,761 Cr733 Cr
₹693.009.986,252 Cr1.992.31%21.71%25.26%5,464 Cr626 Cr
₹884.0014.843,941 Cr2.340.23%21.17%27.37%2,071 Cr268 Cr
₹188.1717.093,659 Cr1.671.58%9.68%12.75%2,631 Cr214 Cr
Crop Life Science (this company)
₹82.00—141 Cr1.670.00%7.38%15.58%——
Median 8 companies₹618.6020.2210,528 Cr2.170.94%13.88%18.28%5,464 Cr626 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

46 Average
Overall score

Data confidence 84/100

surveillance:ESM1

Category scores

Quality Average 52
Returns, margins, earnings quality 22% weight
Valuation Weak 43
Cheap vs sector & own history 24% weight
Growth Weak 39
Sales & profit trajectory 9% weight
Financial Health Poor 32
Solvency, leverage, coverage 9% weight
Momentum Strong 99
Trend strength, vol-adjusted 12% weight
Ownership Weak 38
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Weaknesses

3
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -2.80%
  • Company has a low return on equity of 9.02% over last 3 years.

Technical Indicators

Oscillators

Bearish

Bearish
4
Neutral
2
Bullish
3

Overall

Bullish

Bearish
4
Neutral
2
Bullish
13

Moving Averages

Bullish

Bearish
0
Neutral
0
Bullish
10

Growth Rate

Revenue Growth
3.62% lower than 3Y

change over 1 year

Net Income Growth
16.07% lower than 3Y

change over 1 year

Cash Flow Change
-409%

change over 1 year

EBITDA Margin Change
8.46%

change over 1 year Operating margin 10% · Mar 2026

Quarterly Results

Particulars Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
79
52
97
101
106
94
120
87
Expenses
75
45
91
95
98
87
112
78
Operating Profit
5
7
6
6
8
8
8
9
OPM %
6%
13%
7%
6%
8%
8%
7%
10%
Other Income
0
1
1
1
0
1
1
1
Interest
1
2
1
2
2
2
3
3
Depreciation
1
3
2
2
2
2
2
2
PBT
2
3
4
4
4
5
4
6
Tax %
62%
-1%
20%
32%
23%
30%
26%
32%
Net Profit
1
3
3
3
3
3
3
4
EPS (₹)
0.78
2.61
1.96
1.56
2.01
1.86
1.88
2.19
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
126
107
94
130
191
196
203
Expenses
118
98
86
118
178
180
186
Operating Profit
8
9
8
12
13
16
17
OPM %
7%
8%
8%
9%
7%
8%
8%
Other Income
0
1
0
1
2
1
2
Interest
2
2
2
3
3
5
5
Depreciation
2
3
2
4
3
3
3
PBT
5
5
4
6
8
9
10
Tax %
30%
25%
25%
27%
26%
26%
29%
Net Profit
3
4
3
4
6
7
7
EPS (₹)
2.69
3.08
2.34
3.39
3.52
3.86
4.08
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
12
12
12
12
17
17
17
Reserves
18
21
24
29
55
61
68
Borrowings
16
18
22
27
34
44
57
Other Liabilities
31
35
37
34
67
55
63
Total Liabilities
76
86
95
102
172
178
205
Fixed Assets
12
13
11
16
22
22
16
CWIP
0
0
1
0
0
0
0
Investments
0
0
0
0
12
13
13
Other Assets
64
73
82
86
138
142
177
Total Assets
76
86
95
102
172
178
205
Figures in ₹ Crores

Cash Flow

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
3
4
0
2
-8
-2
-8
Investing
-1
-2
-2
-4
-16
-4
2
Financing
-3
-1
1
1
24
-5
-9
Net Cash Flow
-1
1
-1
-2
0
-11
-15
Free Cash Flow
2
1
-2
-3
-13
-5
-4
CFO/EBITDA
46
58
11
34
-49
3
-31
Figures in ₹ Crores

Ratios

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
80
89
143
92
148
129
134
Inventory Days
93
159
137
104
99
126
170
Days Payable
72
108
137
79
131
113
127
Cash Conversion Cycle
100
140
143
116
117
141
177
Working Capital Days
50
74
93
86
86
89
105
ROCE %
—
14%
11%
14%
13%
12%
12%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Crop Life Science insights

60 extracted metrics + investor summaries across FY20–FY26.

Shareholding Pattern

Promot.67.21%Others8.63%Public24.15%As ofSep 2026
2.08% of promoter holding pledged as of 14 Oct 2026

Documents

Frequently Asked Questions about Crop Life Science

What does Crop Life Science Ltd do?
Incorporated in 2006, Crop Life Sciences Ltd manufactures and deals in pesticides, insecticides, herbicide, fertilizers and allied products related to research and technical formulations[1]
Where is Crop Life Science Ltd (CLSL) listed?
Crop Life Science Ltd trades as CLSL on the NSE.
Which sector does Crop Life Science Ltd belong to?
Crop Life Science Ltd is classified under the Chemicals sector, in the Pesticides & Agrochemicals industry.
What is the market capitalisation of Crop Life Science Ltd?
Crop Life Science Ltd has a market capitalisation of ₹140.55 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Crop Life Science Ltd?
Over the last 52 weeks Crop Life Science Ltd has traded between ₹39.05 and ₹92.25 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Crop Life Science Ltd?
Crop Life Science Ltd reported a return on equity of 7.38%. Its debt-to-equity ratio is 0.67.

Company Information

Incorporated in 2006, Crop Life Sciences Ltd manufactures and deals in pesticides, insecticides, herbicide, fertilizers and allied products related to research and technical formulations[1]

Listed 2023-08-30
Face Value ₹ 10
Shares Outstanding 1,71,40,000

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/CLSL.md for Crop Life Science Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More